March 2026
1. VAGNET A, Ferraj M, Dobi E, Valnet Rabier MB, et al
   Pregnancy during pembrolizumab therapy for triple-negative breast cancer with onset of congenital hypothyroidism: Case report, literature review, and caution for clinical practice.
   Semin Oncol. 2026;53:152486.
   

   >> Share

   
   January 2026
2. MARTIN-QUESADA AI, Martin-Abreu C
   Advances in the management of metastatic lobular breast cancer: Current evidence and emerging treatments.
   Semin Oncol. 2026;53:152466.
   

   >> Share

   
   July 2025
3. SAMAD MA, Ahmad I, Asghar MN, Suhail M, et al
   MicroRNAs: From bench to bedside applications as breast cancer therapsseutics.
   Semin Oncol. 2025;52:152386.
   

   >> Share

   
   June 2025
4. MOHAMMAD SI, Theab EY, Vasudevan A, Bishoyi AK, et al
   Breast cancer exosomes: Managing macrophage polarization and immune regulation in the tumor microenvironment.
   Semin Oncol. 2025;52:152365.
   

   >> Share

   
   
5. EBRAHIMI A, Ghavi D, Mirzaei Z, Barati T, et al
   A 3-miRNA signature for noninvasive breast cancer detection.
   Semin Oncol. 2025;52:152363.
   

   >> Share

   
   April 2025
6. SASI N, Preetha D, Iyyappan S, Selvamurugan N, et al
   Circular RNAs: Emerging regulators of signaling pathways in epithelial-mesenchymal transition and angiogenesis during breast cancer progression.
   Semin Oncol. 2025;52:152340.
   

   >> Share

   
   October 2024
7. MESA-CHAVEZ F, Salazar-Alejo M, Villarreal-Garza C
   Screening Adherence for Second Primary Malignancies in Breast Cancer Survivors: Behaviors, Facilitators, and Barriers to Enhance Quality Care.
   Semin Oncol. 2024 Oct 28:S0093-7754(24)00055.
   

   >> Share

   
   May 2024
8. CORSO G, Fusco N, Guerini-Rocco E, Leonardi MC, et al
   Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment.
   Semin Oncol. 2024 May 20:S0093-7754(24)00038.
   

   >> Share

   
   February 2024
9. SOBRINI-MORILLO P, Ravot C, Herledan C, Sanchez-Castellano C, et al
   Real-world experience with CDK4-6 inhibition in the old and oldest old with a diagnosis of breast cancer.
   Semin Oncol. 2024 Feb 22:S0093-7754(24)00003.
   

   >> Share

   
   June 2023
10. FERRO A, Generali D, Caffo O, Caldara A, et al
    Oral selective estrogen receptor degraders (SERDs): The new emperors in breast cancer clinical practice?
    Semin Oncol. 2023;50.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share